Company Filing History:
Years Active: 2004-2009
Title: Innovations of Inventor Gregory Lee White in Vaccine Development
Introduction
Gregory Lee White, an accomplished inventor based in Montreal, Canada, has made significant contributions to the field of immunology through his innovative patents. With a portfolio that includes three patents, he has been instrumental in the development of advanced vaccine technologies that hold promise for enhancing immune responses.
Latest Patents
Among his notable inventions is the "Proteosome-liposaccharide vaccine adjuvant," which involves a complex of bacterial outer membrane protein proteosomes combined with bacterial liposaccharides. This innovative adjuvant is designed to formulate immunogenic compositions, vaccines, and immunotherapeutics that can induce protective antibodies and type 1 cytokines across various protocols.
Another key invention is the "Proteosome influenza vaccine," which describes improved vaccine formulations containing proteosomes and protein antigens. These vaccines, particularly those utilizing influenza hemagglutinin as the antigen, exemplify improvements in both preparation and efficacy related to the proteosome component.
Career Highlights
Gregory Lee White works at Id Biomedical Corporation of Quebec, where his research and innovations focus predominantly on vaccine development. His work exemplifies a commitment to advancing medical technologies through rigorous research and development.
Collaborations
Throughout his career, White has collaborated with esteemed colleagues, including David S. Burt and David Hugh Jones. These partnerships have facilitated the innovation of novel solutions in vaccine technology, reflecting the importance of teamwork in scientific advancement.
Conclusion
Gregory Lee White's contributions to vaccine innovation are noteworthy and continue to impact the field of immunology positively. His work, particularly in the realm of proteosome-based vaccines, underscores the importance of innovation in addressing public health challenges. Through his patents, White has positioned himself as a key figure in the ongoing effort to enhance vaccine efficacy and improve global health outcomes.